162 related articles for article (PubMed ID: 36082935)
1. A novel small positive allosteric modulator of neuropeptide receptor PAC1-R exerts neuroprotective effects in MPTP mouse Parkinson's disease model.
Fan G; Chen S; Tao Z; Zhang H; Yu R
Acta Biochim Biophys Sin (Shanghai); 2022 Sep; 54(9):1349-1364. PubMed ID: 36082935
[TBL] [Abstract][Full Text] [Related]
2. The allosteric modulation effects of doxycycline, minocycline, and their derivatives on the neuropeptide receptor PAC1-R.
Song S; Wang L; Li J; Huang X; Yu R
Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):627-637. PubMed ID: 31056648
[TBL] [Abstract][Full Text] [Related]
3. Novel Small Molecule Positive Allosteric Modulator SPAM1 Triggers the Nuclear Translocation of PAC1-R to Exert Neuroprotective Effects through Neuron-Restrictive Silencer Factor.
Fan G; Chen S; Liang L; Zhang H; Yu R
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555637
[TBL] [Abstract][Full Text] [Related]
4. TAT-tagging of VIP exerts positive allosteric modulation of the PAC1 receptor and enhances VIP neuroprotective effect in the MPTP mouse model of Parkinson's disease.
Yu R; Li J; Lin Z; Ouyang Z; Huang X; Reglodi D; Vaudry D
Biochim Biophys Acta Gen Subj; 2020 Aug; 1864(8):129626. PubMed ID: 32335135
[TBL] [Abstract][Full Text] [Related]
5. Doxycycline exerted neuroprotective activity by enhancing the activation of neuropeptide GPCR PAC1.
Yu R; Zheng L; Cui Y; Zhang H; Ye H
Neuropharmacology; 2016 Apr; 103():1-15. PubMed ID: 26700245
[TBL] [Abstract][Full Text] [Related]
6. Positive allosteric regulation of PAC1-R up-regulates PAC1-R and its specific ligand PACAP.
Fan G; Tao Z; Chen S; Zhang H; Yu R
Acta Biochim Biophys Sin (Shanghai); 2022 May; 54(5):657-672. PubMed ID: 35593471
[TBL] [Abstract][Full Text] [Related]
7. PACAP/PAC1-R activation contributes to hyperalgesia in 6-OHDA-induced Parkinson's disease model rats via promoting excitatory synaptic transmission of spinal dorsal horn neurons.
Dong LG; An MQ; Gu HY; Zhang LG; Zhang JB; Li CJ; Mao CJ; Wang F; Liu CF
Acta Pharmacol Sin; 2023 Dec; 44(12):2418-2431. PubMed ID: 37563446
[TBL] [Abstract][Full Text] [Related]
8. Design and biological assessment of membrane-tethering neuroprotective peptides derived from the pituitary adenylate cyclase-activating polypeptide type 1 receptor.
Poujol de Molliens M; Jamadagni P; Létourneau M; Devost D; Hébert TE; Patten SA; Fournier A; Chatenet D
Biochim Biophys Acta Gen Subj; 2019 Nov; 1863(11):129398. PubMed ID: 31306709
[TBL] [Abstract][Full Text] [Related]
9. Novel splice variants of type I pituitary adenylate cyclase-activating polypeptide receptor in frog exhibit altered adenylate cyclase stimulation and differential relative abundance.
Alexandre D; Vaudry H; Grumolato L; Turquier V; Fournier A; Jégou S; Anouar Y
Endocrinology; 2002 Jul; 143(7):2680-92. PubMed ID: 12072402
[TBL] [Abstract][Full Text] [Related]
10. Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective Peptide.
Bourgault S; Vaudry D; Dejda A; Doan ND; Vaudry H; Fournier A
Curr Med Chem; 2009; 16(33):4462-80. PubMed ID: 19835562
[TBL] [Abstract][Full Text] [Related]
11. Hormesis effect of hydrogen peroxide on the promoter activity of neuropeptide receptor PAC1-R.
Huang X; Li J; Song S; Wang L; Lin Z; Ouyang Z; Yu R
J Food Biochem; 2019 Jul; 43(7):e12877. PubMed ID: 31353704
[TBL] [Abstract][Full Text] [Related]
12. In Silico Screening Identified Novel Small-molecule Antagonists of PAC1 Receptor.
Takasaki I; Watanabe A; Yokai M; Watanabe Y; Hayakawa D; Nagashima R; Fukuchi M; Okada T; Toyooka N; Miyata A; Gouda H; Kurihara T
J Pharmacol Exp Ther; 2018 Apr; 365(1):1-8. PubMed ID: 29363578
[TBL] [Abstract][Full Text] [Related]
13. Pituitary adenylyl cyclase-activating polypeptide (PACAP) and its receptor (PAC1-R) in the cochlea: evidence for specific transcript expression of PAC1-R splice variants in rat microdissected cochlear subfractions.
Abu-Hamdan MD; Drescher MJ; Ramakrishnan NA; Khan KM; Toma VS; Hatfield JS; Drescher DG
Neuroscience; 2006 Jun; 140(1):147-61. PubMed ID: 16626868
[TBL] [Abstract][Full Text] [Related]
14. Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects.
Doan ND; Bourgault S; Dejda A; Létourneau M; Detheux M; Vaudry D; Vaudry H; Chatenet D; Fournier A
Biochem Pharmacol; 2011 Feb; 81(4):552-61. PubMed ID: 21114961
[TBL] [Abstract][Full Text] [Related]
15. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Enhances Hippocampal Synaptic Plasticity and Improves Memory Performance in Huntington's Disease.
Cabezas-Llobet N; Vidal-Sancho L; Masana M; Fournier A; Alberch J; Vaudry D; Xifró X
Mol Neurobiol; 2018 Nov; 55(11):8263-8277. PubMed ID: 29526016
[TBL] [Abstract][Full Text] [Related]
16. Characterization and messenger ribonucleic acid distribution of a cloned pituitary adenylate cyclase-activating polypeptide type I receptor in the frog Xenopus laevis brain.
Hu Z; Lelievre V; Chao A; Zhou X; Waschek JA
Endocrinology; 2000 Feb; 141(2):657-65. PubMed ID: 10650947
[TBL] [Abstract][Full Text] [Related]
17. Alteration of the PAC1 Receptor Expression in the Basal Ganglia of MPTP-Induced Parkinsonian Macaque Monkeys.
Feher M; Gaszner B; Tamas A; Gil-Martinez AL; Fernandez-Villalba E; Herrero MT; Reglodi D
Neurotox Res; 2018 May; 33(4):702-715. PubMed ID: 29230633
[TBL] [Abstract][Full Text] [Related]
18. Characterizations of a synthetic pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular side effects in a Parkinson's disease model.
Lamine A; Létourneau M; Doan ND; Maucotel J; Couvineau A; Vaudry H; Chatenet D; Vaudry D; Fournier A
Neuropharmacology; 2016 Sep; 108():440-50. PubMed ID: 26006268
[TBL] [Abstract][Full Text] [Related]
19. A structure-function study of PACAP using conformationally restricted analogs: Identification of PAC1 receptor-selective PACAP agonists.
Ramos-Álvarez I; Mantey SA; Nakamura T; Nuche-Berenguer B; Moreno P; Moody TW; Maderdrut JL; Coy DH; Jensen RT
Peptides; 2015 Apr; 66():26-42. PubMed ID: 25698233
[TBL] [Abstract][Full Text] [Related]
20. Pituitary adenylate cyclase activating polypeptide-mediated intracrine signaling in the testicular germ cells.
Li M; Funahashi H; Mbikay M; Shioda S; Arimura A
Endocrine; 2004 Feb; 23(1):59-75. PubMed ID: 15034198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
